In the News
PRNewswire - February 25, 2020
TwinStrand Biosciences Launches Duplex Sequencing Technology
TwinStrand Duplex Sequencing™ Technology officially launched at the 2020 Advances in Genome Biology and Technology (AGBT) General Meeting. Initially, the company will offer kits for two research applications: detection of minimal residual disease in acute myeloid leukemia (AML MRD) and a multi-species genetic toxicology assay for rapid identification of carcinogenic chemicals in preclinical testing, as well as detection of patients who have been environmentally exposed.
X
TwinStrand Biosciences Launches Duplex Sequencing Technology
Timmerman Report - June 15, 2020
Timmerman Report- DNA Sequencing Startups Aim to Reduce Cost, Increase Meaning in the Data
GEN - April 1, 2020
Sequencing’s Stars Urge Exploration of New Dimensions
GEN - March 1, 2020
Genomic Medicine Identifies Reconcilable Differences
DeciBio - February 27, 2020
AGBT 2020: DeciBio Highlights – Spatial Profiling Reloaded & MGI Unleashed 2
PRNewswire - February 25, 2020
TwinStrand Biosciences Launches Duplex Sequencing Technology
LinkedIn - January 7, 2020
Leveraging big data to improve genome sequencing accuracy by 10,000x
